Cargando…

Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an RNA-binding protein and serves as a post-transcriptional fine-tuner regulating the expression of mRNA targets. However, the clinicopathological roles of IGF2BP1 in colorectal cancer (CRC) remains limited. Thus, we aimed to elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hung-Ming, Lin, Chun-Chi, Chen, Wei-Shone, Jiang, Jeng-Kai, Yang, Shung-Haur, Chang, Shih-Ching, Ho, Ching-Liang, Yang, Chung-Chi, Huang, Shih-Ching, Chao, Yee, Liao, Tsai-Tsen, Hwang, Wei-Lun, Teng, Hao-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267666/ https://www.ncbi.nlm.nih.gov/pubmed/34203267 http://dx.doi.org/10.3390/ijms22136940

Ejemplares similares

Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients
por: Kuan, Tai-Chuan, et al.
Publicado: (2018)

Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer
por: Liao, Tsai-Tsen, et al.
Publicado: (2020)

A Long-Term and Large-Scale Real-World Study in Taiwan: Efficacy of Target Therapy in Stage IV Colorectal Cancer
por: Huang, Sheng-Chieh, et al.
Publicado: (2022)

A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer
por: Lin, Pei-Ching, et al.
Publicado: (2015)

Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway
por: Tsai, Hong-Chieh, et al.
Publicado: (2021)

Author Correction: Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway
por: Tsai, Hong-Chieh, et al.
Publicado: (2021)

The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study
por: Chang, Che-Yuan, et al.
Publicado: (2022)

Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences
por: Chang, Shih‐Ching, et al.
Publicado: (2019)

Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report
por: Lin, Hung-Hsin, et al.
Publicado: (2016)

Three-dimensional versus conventional two-dimensional laparoscopic colectomy for colon cancer: A 3-year follow-up study
por: Yang, Yi-Wen, et al.
Publicado: (2022)

Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women
por: Huang, Chi-Jung, et al.
Publicado: (2016)

The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon
por: Lee, Kun-Han, et al.
Publicado: (2021)

Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients
por: Lu, Chieh-Sheng, et al.
Publicado: (2016)

Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer
por: Chang, Chu-Cheng, et al.
Publicado: (2017)

Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread
por: Hsu, Hung-Chih, et al.
Publicado: (2021)

Differences in gene mutations according to gender among patients with colorectal cancer
por: Tsai, Yi-Jian, et al.
Publicado: (2018)

Clinicopathological analysis of colorectal carcinoid tumors and patient outcomes
por: Lin, Hung-Hsin, et al.
Publicado: (2014)

Risk factors for delayed perineal wound healing and its impact on prolonged hospital stay after abdominoperineal resection
por: Chang, Chu-Cheng, et al.
Publicado: (2019)

Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
por: Chang, Shih-Ching, et al.
Publicado: (2020)

ER stress‐related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer
por: Liu, Chun‐Yu, et al.
Publicado: (2018)

Clinical relevance of cell-free DNA in gastrointestinal tract malignancy
por: Lan, Yuan-Tzu, et al.
Publicado: (2016)

Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer()()
por: Fan, Li-Ching, et al.
Publicado: (2015)

Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?
por: Tsai, Yi-Jian, et al.
Publicado: (2016)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
por: Yang, Kai-Lin, et al.
Publicado: (2013)

The Prognostic Role of Para-Aortic Lymph Nodes in Patients with Colorectal Cancer: Is It Regional or Distant Disease?
por: Lu, Hsueh-Ju, et al.
Publicado: (2015)

m(6)A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
por: Lang, Chuandong, et al.
Publicado: (2021)

Integrative Analyses of mRNA Expression Profile Reveal the Involvement of IGF2BP1 in Chicken Adipogenesis
por: Chen, Jiahui, et al.
Publicado: (2019)

Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-β2 expression
por: Liao, Ko-Hsun, et al.
Publicado: (2017)

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer
por: Huang, Xinwei, et al.
Publicado: (2018)

Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy
por: Chen, Kuen-Feng, et al.
Publicado: (2015)

FTO Inhibits Epithelial Ovarian Cancer Progression by Destabilising SNAI1 mRNA through IGF2BP2
por: Sun, Meige, et al.
Publicado: (2022)

Tagged actin mRNA dysregulation in IGF2BP1 [Formula: see text] mice
por: Núñez, Leti, et al.
Publicado: (2022)

Building personalized treatment plans for early-stage colorectal cancer patients
por: Lin, Hung-Hsin, et al.
Publicado: (2017)

Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications
por: Lin, Shu-Hui, et al.
Publicado: (2022)

Prognostic Values of EPDR1 Hypermethylation and Its Inhibitory Function on Tumor Invasion in Colorectal Cancer
por: Chu, Chun-Ho, et al.
Publicado: (2018)

PADI2‐Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1‐Mediated SOX2 mRNA Stability in Endometrial Cancer
por: Xue, Teng, et al.
Publicado: (2021)

Recognition of RNA N(6)-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation
por: Huang, Huilin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4bue2gru8jd2qt33kr6o1cve5c